BRÈVE publiée le 26/09/2025 à 14:50, il y a 1 année 1 mois EnVVeno Medical Engages in Virtual Investor Segment Amid FDA Appeal Medical Devices EnVVeno Medical VenoValve Chronic Venous Insufficiency FDA Appeal
COMMUNIQUÉ DE PRESSE publié le 26/09/2025 à 14:45, il y a 1 année 1 mois enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment enVVeno Medical Corporation announces CEO Robert Berman's participation in a Virtual Investor segment discussing the supervisory appeal for VenoValve® with FDA FDA EnVVeno Medical VenoValve Virtual Investor Supervisory Appeal
BRÈVE publiée le 15/09/2025 à 14:50, il y a 1 année 1 mois EnVVeno Medical dépose un recours auprès de la FDA EnVVeno Medical Insuffisance Veineuse Chronique Valve VenoValve Appel Auprès De La FDA Processus Réglementaire
BRÈVE publiée le 15/09/2025 à 14:50, il y a 1 année 1 mois EnVVeno Medical Pursues FDA Supervisory Appeal EnVVeno Medical VenoValve Chronic Venous Insufficiency Regulatory Process FDA Appeal
COMMUNIQUÉ DE PRESSE publié le 15/09/2025 à 14:45, il y a 1 année 1 mois enVVeno Medical Updates Regulatory Status of VenoValve(R) enVVeno Medical Corporation to file supervisory appeal with FDA regarding not-approvable letter for VenoValve® submission to treat deep venous CVI, aiming to bring innovative solution to patients FDA EnVVeno Medical Corporation VenoValve® Deep Venous Disease Supervisory Appeal
BRÈVE publiée le 20/08/2025 à 13:05, il y a 1 année 2 mois EnVVeno Medical Receives Not-Approvable Letter from FDA for VenoValve EnVVeno Medical VenoValve FDA Decision Deep Venous Disease Premarket Approval
BRÈVE publiée le 20/08/2025 à 13:05, il y a 1 année 2 mois EnVVeno Medical reçoit une lettre de non-approbation de la FDA pour VenoValve EnVVeno Medical Valve VenoValve Décision De La FDA Maladie Veineuse Profonde Approbation Préalable À La Mise Sur Le Marché
COMMUNIQUÉ DE PRESSE publié le 20/08/2025 à 13:00, il y a 1 année 2 mois enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) enVVeno Medical received a not-approvable letter from the FDA for VenoValve, citing lacking hemodynamic data and safety concerns. Company to work on new criteria and potential resubmission FDA Medical Device EnVVeno Medical VenoValve CVI
BRÈVE publiée le 15/08/2025 à 15:26, il y a 1 année 2 mois EnVVeno Medical participera à la série de webinaires financiers Webull EnVVeno Medical Valve VenoValve Maladie Veineuse Profonde Webull Financial Biotechnologie/Technologie Médicale
BRÈVE publiée le 15/08/2025 à 15:26, il y a 1 année 2 mois EnVVeno Medical to Present at Webull Financial Webinar Series EnVVeno Medical VenoValve Deep Venous Disease Webull Financial Biotech/MedTech
Publié le 05/11/2026 à 07:00, il y a 2 heures 15 minutes Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Publié le 05/11/2026 à 07:00, il y a 2 heures 15 minutes Eurazeo’s European asset management platform continues to gain momentum, driven by sustained international fundraising
Publié le 05/11/2026 à 07:00, il y a 2 heures 15 minutes Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
Publié le 05/11/2026 à 08:00, il y a 1 heure 15 minutes Caledonia Mining Corporation Plc: Caledonia Group Signs US$150 Million Interim Financing Facilities Agreement to Support Construction of the Bilboes Gold Project
Publié le 04/11/2026 à 23:10, il y a 10 heures 5 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 10 heures 15 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 11 heures Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 05/11/2026 à 09:05, il y a 9 minutes SINBON Links Executive Pay to ESG, Cuts Scope 1 and 2 Emissions 27.68% in 2025 Sustainability Report
Publié le 05/11/2026 à 09:03, il y a 11 minutes u-blox sets a new size benchmark for antenna-integrated GNSS with the SAM-M11N
Publié le 05/11/2026 à 09:02, il y a 12 minutes RHÖN-KLINIKUM AG reports results for the third quarter of 2026
Publié le 05/11/2026 à 09:00, il y a 15 minutes Original-Research: ZEAL Network SE (von NuWays AG): BUY
